Skip to main content
Premium Trial:

Request an Annual Quote

Lophius Biosciences Raises $2M in Private Financing

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lophius Biosciences today announced that it has raised €1.4 million ($2 million) in a round of private financing.

The Regensburg, Germany-based startup is developing T-cell-based diagnostics and also provides cell-based assay testing for pharmaceuticals.

It said that the funds will be used to support the launch of its T-Track CMV/EBV tests in the transplantation field. The firm also said that it will use the proceeds to further develop a test for differential diagnosis of tuberculosis and a test for multiple sclerosis.

Lophius' existing investors, S-Refit and High-Tech Grϋnderfonds, and Bayernkapital participated in the financing round.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.